U.S. Non Invasive Prenatal Testing Market (2023 - 2030) Size, Share & Trends Analysis Report By Gestation Period, By Risk, By Method, By Technology, By Product, By Application (Trisomy, Microdeletion Syndrome), By End-use, And Segment Forecasts

Market Segmentation

U.S. NIPT Gestation Period Outlook (Volume, Number of Tests in Thousands; Revenue, USD Million, 2018 - 2030)
- 0-12 weeks
- 13-24
- 25-35 weeks
U.S. NIPT Risk Outlook (Revenue, USD Million, 2018 - 2030)
- High & Average Risk
- Low Risk
U.S. NIPT Method Outlook (Volume, Number of Tests in Thousands; Revenue, USD Million, 2018 - 2030)
- Biochemical Screening Tests
- Cell-free DNA in Maternal Plasma Tests
U.S. NIPT Technology Outlook (Revenue, USD Million, 2018 - 2030)
- NGS
- Array Technology
- PCR
- Others
U.S. NIPT Product Outlook (Revenue, USD Million, 2018 - 2030)
- Consumables & Reagents
- Instruments
U.S. NIPT Application Outlook (Revenue, USD Million, 2018 - 2030)
- Trisomy
- Microdeletion Syndrome
- Other Applications
U.S. NIPT End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & Clinics
- Diagnostic Laboratories

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments